摘要 |
The present invention relates to a method of treating patients suffering from colorectal cancer, more specifically BRAF V600E -mutant or BRAF wild type, but KRAS wild type and microsatellite-unstable colorectal cancer by using a Wnt pathway inhibitor or a combination comprising a Wnt pathway inhibitor and either a BRAF inhibitor, or an EGFR inhibitor, or both. The disclosure also relates to corresponding pharmaceutical formulations, uses, methods, combinations, and related disclosure embodiments. |
申请人 |
NOVARTIS AG;BAGDASARIAN, LINDA;CONG, FENG;JAEGER, SAVINA;CLAUGHLIN, MARGARET ELISE;MEYER, RONALD;MYERS, ANDREA;PALMER, MICHAEL ROSS;WANG, YOUZHEN;WOOLFENDEN, STEPHEN DAVID;VIVANCOS, ANA;PALMER, HÉCTOR |
发明人 |
BAGDASARIAN, LINDA;CONG, FENG;JAEGER, SAVINA;CLAUGHLIN, MARGARET ELISE;MEYER, RONALD;MYERS, ANDREA;PALMER, MICHAEL ROSS;WANG, YOUZHEN;WOOLFENDEN, STEPHEN DAVID;VIVANCOS, ANA;PALMER, HÉCTOR |